Harvard Health Letter

New hope for people with migraine headaches

Scientists are testing a new class of drugs to treat migraine headaches. The drugs would block (inhibit) a brain protein called CGRP that sends pain messages to the body.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »